Search Within

Andriy Derkach

Formats
  1. Meeting Abstract (104)
  2. Journal Article (56)
  3. Research Letter (11)
  4. Correspondence (3)
Groups
  1. Biostatistics Service (174)
  2. Epidemiology and Biostatistics (174)
  3. Population Sciences Research Program (174)
  4. Department of Medicine (160)
  5. Hematologic Malignancies, Division of (159)
  6. Center for Hematologic Malignancies (153)

More Groups

People
  1. Urvi Shah (80)
  2. Malin Hultcrantz (79)
  3. Alexander Lesokhin (78)
  4. Carlyn Rose Tan (71)
  5. Sham Mailankody (71)
  6. Hani Hassoun (70)

More People

Years
  1. 2025 (10)
  2. 2024 (47)
  3. 2023 (44)
  4. 2022 (35)
  5. 2021 (22)
  6. 2020 (16)
Publications
  1. Blood (75)
  2. Clinical Lymphoma, Myeloma and Leukemia (21)
  3. Journal of Clinical Oncology (14)
  4. Blood Advances (10)
  5. Leukemia and Lymphoma (6)
  6. Blood Cancer Journal (5)

More Publications

Publishers
  1. American Society of Hematology (85)
  2. Elsevier Inc. (24)
  3. American Society of Clinical Oncology (14)
  4. Nature Publishing Group (12)
  5. American Association for Cancer Research (8)
  6. Taylor & Francis Group (6)

More Publishers

Results (174)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic efficacy of combined JAK1/2, pan-PIM, and CDK4/6 inhibition in myeloproliferative neoplasms
    Journal Article

    Rampal, R. K.; Pinzon-Ortiz, M.; Hanasoge Somasundara, A. V.; Durham, B.; Koche, R.; Spitzer, B.; Mowla, S.; Krishnan, A.; Li, B.; An, W.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia
    Journal Article

    Xiao, W.; Chan, A.; Waarts, M. R.; Mishra, T.; Liu, Y.; Cai, S. F.; Yao, J.; Gao, Q.; Bowman, R. L.; Koche, R. P.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Research Letter

    Korde, N.; Mastey, D.; Tavitian, E.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Shah, U.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Journal Article

    Maura, F.; Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V. D.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
    Journal Article

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Leongamornlert, D.; Abascal, F.; Zheng-Lin, B.; Yellapantula, V.; Derkach, A.; Geerdens, E.; Diamond, B. T.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy
    Journal Article

    Glass, J. L.; Derkach, A.; Hilden, P.; King, A.; Seo, S. K.; Ahr, K.; Kishtagari, A.; Levine, R. L.; Tallman, M. S.; Douer, D.
    Leukemia Research (2021)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Patterns of human leukocyte antigen class I and class II associations and cancer
    Journal Article

    Liu, Z.; Derkach, A.; Yu, K. J.; Yeager, M.; Chang, Y. S.; Chen, C. J.; Gyllensten, U.; Lan, Q.; Lee, M. H.; McKay, J. D.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: A cohort study from five academic centers
    Journal Article

    Hultcrantz, M.; Richter, J.; Rosenbaum, C. A.; Patel, D.; Smith, E. L.; Korde, N.; Lu, S. X.; Mailankody, S.; Shah, U. A.; Lesokhin, A. M.; more...
    Blood Cancer Discovery (2020)

    Fulltext@MSK | Save
  • VRd versus KRd safety profiles in newly diagnosed multiple myeloma patients using real-world evidence data from a single institution: VRd has high rates of chronic neuropathy, and KRd has low rates of cardiopulmonary or renal toxicities when using optimized IV fluid management coupled with baseline cardiac workup
    Meeting Abstract

    Tan, C.; Diamond, B.; Hultcrantz, M.; Korde, N.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; Lu, S. X.; Patel, D.; more...
    Blood (2020)

    Fulltext@MSK | Save